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Background: In insulin-sensitive cells, such as adipocytes
and skeletal muscle, the activation of phosphoinositide 3-
kinase (PI 3-kinase) is thought to be critical in allowing
insulin to stimulate both the uptake of glucose and the
translocation of a specialized glucose transporter, GLUT4,
to the plasma membrane. However, the downstream medi-
ators that couple PI 3-kinase to GLUT4 translocation are
still not known. Recent studies have shown that the GTP-
binding protein Rac mediates some of the biological effects
of PI 3-kinase, and these findings,have led to the sugges-
tion that Rac may be a common mediator for a variety of
responses mediated by PI 3-kinase. To determine whether
Rac couples PI 3-kinase to glucose uptake in adipocytes,
we produced 3T3-L1 cells expressing either a constitu-
tively active Racl (V12 Racl, containing a valine residue
at position 12) or a dominant-inhibitory Racl (N17 Racl,
containing an asparagine residue at position 17).
Results: The stable expression of both V12 Racl and
N17 Racl led to observable phenotypes in 3T3-L1 cells;
expression of V12 Racl resulted in constitutive formation
of lamellipodia and constitutive activation of the cJun-
N-terminal kinase (NK), whereas expression of
N17 Racl inhibited the insulin-stimulated formation of
lamellipodia. However, neither basal glucose uptake nor
insulin-stimulated glucose uptake was affected by the
expression of either mutant Rac protein. In addition,
expression of V12 Racl did not reverse the inhibition of
insulin-stimulated glucose uptake caused by the PI 3-
kinase inhibitor wortmannin.
Conclusions: These findings provide direct evidence
that PI 3-kinase does not use Rac to couple the insulin
receptor to glucose uptake in adipocytes. Furthermore,
the finding that Rac does not mediate glucose uptake in
response to insulin is consistent with the idea that
PI 3-kinase couples to a variety of different effector mol-
ecules in cells, and suggests that some of the specificity in
the biological responses elicited by PI 3-kinase may be
mediated by the activation of different effector molecules.
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Background
Insulin maintains blood glucose levels by stimulating the
uptake of excess glucose into insulin-sensitive fat and
muscle cells [1,2]. To this end, insulin stimulates the
translocation of a specialized glucose transporter, GLUT4,
from an intracellular compartment to the plasma mem-
brane [1,2]. Only adipose tissue and muscle express
GLUT4 and, as a result, these tissues are primarily
responsible for regulating blood glucose levels after
absorption of glucose from the gut.
The early intracellular signaling events linking the insulin
receptor to GLUT4 translocation and glucose uptake in
fat and muscle are now beginning to be understood.
Ligand binding results in receptor autophosphorylation
and activation of the intrinsic tyrosine-kinase domain of
the insulin receptor [3,4]. The active insulin receptor
tyrosine-phosphorylates a family of 180-190 kDa pro-
teins, including the insulin receptor substrates IRS-1 and
IRS-2, which couple the receptor to downstream signal-
ing pathways by serving as 'docking proteins' for signal-
ing molecules that have Src homology 2 (SH2) domains
[5]. PI 3-kinase is one of the SH2-domain-containing
signaling molecules that is activated by binding to IRS-1
and IRS-2 [6], and is likely to be critical for coupling the
insulin receptor to glucose uptake and GLUT4 trans-
location. This suggestion is supported by the findings
that IRS-1 gene 'knockout' mice are resistant to insulin,
and that pharmacological inhibitors of PI 3-kinase block
glucose uptake in adipocytes [7-10].
PI 3-kinase catalyzes phosphorylation of the 3-OH
group of phosphatidylinositol (PI) [11-13]. Activation of
PI 3-kinase by the insulin receptor leads to a rapid
increase in the formation of intracellular PI(3,4,5)-tris-
phosphate (PI(3,4,5)-P 3) [14,15]. It is thought that
PI(3,4,5)-P 3 functions directly as a second messenger to
mediate cellular responses [13,15,16]. Although several
downstream targets of PI 3-kinase have now been identi-
fied [17-19], the mechanism whereby PI 3-kinase cou-
ples the insulin receptor to glucose uptake and GLUT4
translocation in insulin-sensitive cells is still not known.
Several lines of experimental evidence have identified the
small GTP-binding protein Rac as one of the targets for
PI 3-kinase activation [19]. First, activation of a variety of
diverse cellular processes requires the activation of both
PI 3-kinase and Rac. For example, both Rac and PI 3-
kinase are likely to be involved in superoxide generation
in neutrophils and regulated secretion in mast cells and
basophils [20-24]. In addition, activation of both Rac
and PI 3-kinase is required for growth factors, such as
insulin and platelet-derived growth factor (PDGF), to
induce actin reorganization, which leads to the formation
of lamellipodia [25-27].
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The second observation implicating Rac as a mediator of
PI 3-kinase action comes from studies demonstrating that
PI 3-kinase lies upstream of Rac on a signaling pathway
stimulated by receptor tyrosine kinases. It has been
shown that treatment of cells with various PI 3-kinase
inhibitors blocks the formation of lamellipodia induced
by PDGF, and that the ability of PI 3-kinase inhibitors to
block lamellipodial formation is antagonized by the
expression of a constitutively active Rac protein [25,26].
In addition, PI 3-kinase has been shown to mediate the
increase in Rac bound to GTP (the active form of Rac)
in cells stimulated with PDGF [26]. Thus, the finding
that PI 3-kinase sits upstream of Rac on a signaling
pathway has led to the suggestion that Rac is a common
mediator of the various biological effects that follow
PI 3-kinase activation.
With respect to a possible role for Rac in mediating
glucose uptake by insulin, previous studies have also
shown that activation of one or more GTP-binding pro-
tein(s) in adipocytes by GTP-yS (a non-hydrolyzable ana-
logue of GTP) stimulates GLUT4 translocation [28].
This finding, coupled with the demonstration that PI 3-
kinase activates Rac and is required for GLUT4 translo-
cation, raises that possibility that both GTP-yS and
PI 3-kinase stimulate GLUT4 translocation by activating
Rac. Although the mechanism whereby Rac could cou-
ple PI 3-kinase to glucose transport is not clear, reorgani-
zation of the actin cytoskeleton is one possibility.
Alternatively, Rac might couple PI 3-kinase to GLUT4
translocation by activating a kinase cascade which then
activates GLUT4 translocation; Rac has been shown to
trigger a kinase cascade resulting in activation of the
cJun-N-terminal kinase NK) [29,30].
We wanted to determine whether Rac mediates insulin-
stimulated glucose uptake and GLUT4 translocation in an
insulin-sensitive 3T3-L1 adipocyte cell line. We reasoned
that, if activation of Rac by PI 3-kinase is necessary for
PI 3-kinase to stimulate glucose uptake, inhibition of Rac
should block insulin-stimulated glucose transport in
adipocytes. In this paper, we show that although expres-
sion of the dominant-inhibitory N17 Racl caused a
marked reduction in insulin-stimulated actin reorganiza-
tion, as assessed by the formation of lamellipodia, insulin-
stimulated glucose uptake was not inhibited. Moreover,
expression of the constitutively active V12 Racl did not
antagonize the ability of the PI 3-kinase inhibitor wort-
mannin to block glucose uptake by insulin. These find-
ings indicate that Rac is not on a signaling pathway
linking the insulin receptor to glucose uptake.
causes constitutive activation, whereas N17 Racl has an
asparagine residue at position 17, which has been shown
to have a dominant-inhibitory function, inhibiting endo-
genous Rac [32]. Geneticin-resistant pools and clones of
3T3-L1 cells were isolated, and overexpression of the
Rac proteins was determined in cell lysates by immuno-
blotting using the 9E10 antibody, which recognizes the
Myc-epitope tag (Fig. 1) [33]. The levels of the Rac pro-
teins in the transfected cells, relative to those of endo-
genous Rac, were not determined because good
anti-Rac antibodies were not available.
V12 Racl causes the constitutive formation of lamellipodia
and activation of JNK in serum-starved 3T3-L1 cells
Expression of V12 Rac has previously been shown to
cause reorganization of the actin cytoskeleton, leading to
the constitutive formation of lamellipodia [32]. To verify
that expression of V12 Racl has a meaningful biological
effect in 3T3-L1 cells, we measured lamellipodial forma-
tion in 3T3-L1 cells expressing V12 Racl. Serum-
starved control and V12 Racl-expressing 3T3-L1
fibroblasts were either not stimulated or stimulated with
100 nM insulin for 5 minutes, and lamellipodial forma-
tion was assessed by immunofluorescence microscopy
using FITC-phalloidin. Only a few membrane ruffles
and lamellipodia were detected in serum-starved parental
3T3-L1 cells, and the percentage of cells expressing
lamellipodia increased markedly after insulin stimulation
(Figs 2a,c). In contrast to control cells, however, most
serum-starved 3T3-L1 fibroblasts expressing V12 Racl
constitutively formed lamellipodia in the absence of
insulin stimulation (Figs 2a,c), and exhibited circular
membrane ruffles possibly as a result of high levels of
Rac activity [26].
In addition, although the PI 3-kinase inhibitor
wortmannin blocked the formation of lamellipodia in
insulin-stimulated control cells, the expression of
V12 Racl antagonized this inhibitory effect (Fig. 2a). To
confirm further that Rac was activated in 3T3-L1 cells
Results
Stable 3T3-L1 cell lines overexpressing V12 Racl and
N17 Racl
3T3-L1 cells were infected with a retroviral construct
that encoded either Myc-epitope-tagged V12 Racl or
N17 Racl [31,32] and conferred resistance to geneticin.
V12 Racl has a valine residue at position 12, which
Fig. 1. Expression of V12 Racl and N17 Racl in 3T3-L1
fibroblasts. 3T3-L1 cells were infected with retroviruses encoding
either V12 Racl or N17 Racl. Geneticin-resistant pools and
clonal cell lines were isolated, lysed and immunoblotted using
the anti-Myc antibody 9E10.
RESEARCH PAPER 1297
1298 Current Biology 1995, Vol 5 No 1
expressing V12 Racl, we measured JNK activity;
V12 Racl has previously been shown to activate a kinase
cascade leading to JNK activation [29,30]. In comparison
to parental cells, JNK activity was markedly elevated in
serum-starved 3T3-L1 cells expressing V12 Racl (Fig.
2b). Thus, the expression of V12 Racl in 3T3-L1 cells
results in the activation of a variety of biological
responses that are normally mediated by activated Rac
proteins.
VI 2 Racl does not reverse wortmannin-induced inhibition
of insulin-stimulated glucose uptake
To determine whether Rac is responsible for coupling
PI 3-kiinase to glucose uptake in insulin-sensitive tissues,
we determined whether expression of V12 Racl pre-
vented wortmannin from inhibiting glucose uptake in
adipocytes. When used at low concentrations
(< 100 nM), wortmannin has been shown to be a
relatively specific inhibitor of PI 3-kinase, and to block
insulin-stimulated glucose uptake in 3T3-L1 adipocytes
[10,21]. We reasoned that, if PI 3-kinase stimulates
glucose uptake by activating Rac, expression of an
activated V12 Racl protein should antagonize the ability
of wortmannin to block glucose uptake in 3T3-L1
adipocytes.
Pools and clones of V12 Racl-expressing 3T3-L1
fibroblasts were then differentiated into adipocytes, which
were assayed for glucose uptake in response to insulin
stimulation in the presence and absence of wortmannin.
Overexpression of V12 Racl did not interfere with the
differentiation of 3T3-L1 fibroblasts into adipocytes, as
determined by the staining of differentiated adipocytes
with oil red O and the analysis of GLUT4 expression by
immunoblotting (data not shown). We did not detect a
difference in glucose uptake between parental control and
V12 Racl-expressing adipocytes; basal and insulin-stimu-
lated glucose uptake were similar in parental adipocytes
and those expressing active V12 Racl (Fig. 3). Moreover,
wortmannin treatment inhibited glucose uptake in both
Fig. 2. Expression of V12 Racl causes
the constitutive formation of lamelli-
podia and activation of JNK in 3T3-L1
cells. Pools of V12 Racl -expressing 3T3-
L1 cells or control cells were serum-
starved for 16 h in Dulbeco's modified
Eagle's medium (DMEM) containing
0.2 % fetal bovine serum (FBS). Cells
were then either not stimulated or stimu-
lated with 100 nM insulin, fixed and
lamellipodia were visualized using
FITC-phalloidin as described in Materi-
als and methods. In (a) 100 cells were
evaluated for lamellipodial formation in
two separate experiments. To determine
the effect of wortmannin on the forma-
tion of lamellipodia, cells were incu-
bated with wortmannin 5 min prior to
stimulation with insulin. (b) Cell lysates(100 ,ug) prepared from either control or
V12 Racl-expressing 3T3-L1 cells were
incubated with 10 ,ug fusion protein,
made up of glutathione-S-transferase and
cjun (GST-cJun), coupled to glutathi-
one-agarose beads. After washing, an in
vitro kinase reaction was performed by
incubating the beads in 50 ,al kinase
buffer containing 15 ICi y-[3 2PIATP.
After incubation for 20 min at 30 C, the
reaction was stopped by boiling in sam-
ple buffer, and the reaction products
were separated by SDS-PAGE (12 % gel)
and phosphorylated GST-cJun was
visualized by autoradiography. (c) Cells
prepared as in (a).
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control and V12 Racl-expressing adipocytes to a similar
extent (Fig. 3); it also inhibited basal glucose uptake to a
similar extent (data not shown). The finding that basal glu-
cose uptake is similar in control and V12 Racl-expressing
cells indicates that activation of Rac is not, by itself, suffi-
cient to stimulate the relocalization of GLUT4 to the
plasma membrane. In addition, the inability of V12 Racl
to antagonize the ability of wortmannin to inhibit glucose
uptake by insulin indicates either that Rac does not couple
PI 3-kinase to glucose transport in adipocytes or that PI 3-
kinase must activate other signaling molecules, in addition
to Rac, in order to stimulate glucose uptake.
N17 Racl does not inhibit glucose uptake in 3T3-L1
adipocytes
Having established that Rac activation is not sufficient for
insulin to stimulate glucose uptake in adipocytes, we
asked whether Rac is even required on this pathway. We
assayed glucose uptake in 3T3-L1 cell lines expressing
N17 Racl; if activation of Rac is critical for glucose
uptake, and if insulin does not activate signaling pathways
that are redundant to Rac function, expression of the
dominant-inhibitory N17 Racl should inhibit insulin-
stimulated glucose uptake.
Fig. 3. Expression of V12 Racl in 3T3-L1 adipocytes does not
affect glucose transport in response to insulin stimulation.
Control or V12 Racl-expressing 3T3-L1 fibroblasts were
differentiated in 12-well plates, as described in Materials and
methods. After overnight serum starvation, adipocytes were
incubated for 20 min at 37 C with 100 nM insulin. 2-deoxy-D-
[3H]glucose was then added and uptake was measured after
10 min; the amount of 2-deoxy-D-[ 3H]glucose taken up was
expressed in terms of protein. Results are plotted as the propor-
tional increase over control values (x control). The mean values
from representative experiments performed in triplicate are
shown. To determine the effect of wortmannin on glucose
uptake, adipocytes were incubated with wortmannin 5 min
prior to stimulation with insulin.
In contrast to the expression of V12 Racl, the expression
of N17 Racl in 3T3-L1 cells was lower and tended to
decrease with the passage of cells in -culture, probably
because of the inhibitory effect of N17 Racl on cell
growth [31]; N17 Racl-expressing 3T3-L1 fibroblasts
grew more slowly and to lower saturation density then
control cells (data not shown). Nevertheless, early pas-
saged geneticin-resistant pools and clonal cell lines of
3T3-L1 cells expressing N17 Racl were obtained, in
which the induction of lamellipodia by insulin was inhib-
ited by 60-80 % (Fig. 4). We were unable to demonstrate
inhibition of JNK activation by N17 Racl in 3T3-L1
adipocytes because insulin did not activate JNK in these
cells. As with 3T3-L1 cells expressing V12 Racl, expres-
sion of N17 Racl did not inhibit the differentiation of
3T3-L1 fibroblasts into adipocytes (data not shown).
Moreover, although expression of N17 Racl significantly
inhibited lamellipodial formation in response to insulin,
insulin-stimulated glucose uptake was similar in control
and N17 Racl-expressing adipocytes. Thus, the activa-
tion of Rac is not even necessary for insulin to stimulate
glucose uptake and GLUT4 translocation in adipocytes.
Discussion
Several studies have now implicated both IRS-1 and
PI 3-kinase as important signaling molecules linking the
insulin receptor to glucose uptake and GLUT4 transloca-
tion [7-10]. Although it is well established that PI 3-
kinase is activated by binding to IRS-1 in
insulin-stimulated cells [5], the events downstream from
PI 3-kinase that mediate GLUT4 translocation are still
not known. A major challenge has been to understand
the mechanism whereby PI 3-kinase couples the insulin
receptor to glucose uptake. In this report, we show that
the GTP-binding protein Rac, which is a prime candi-
date for an effector molecule that mediates cellular
responses involving PI 3-kinase, does not mediate
insulin-stimulated glucose uptake in adipocytes.
It is unlikely that our inability to demonstrate an effect of
the mutant Rac proteins on glucose uptake is due to
inadequate expression of these proteins in 3T3-L1 cells.
We observed the expected phenotypic changes after
expression of the constitutively active V12 Racl and the
dominant-inhibitory N17 Racl in 3T3-L1 cells; expres-
sion of V12 Racl led to the constitutive formation of
lamellipodia and the activation of JNK, whereas expres-
sion of N17 Racl inhibited lamellipodia formation in
response to insulin. In addition, expression of V12 Racl
prevented wortmannin from blocking the induction of
lamellipodia by insulin.
Any model of how PI 3-kinase couples the insulin
receptor to glucose transport must account for PI 3-
kinase mediating specific cellular responses following its
activation by different receptors. Although the most tyro-
sine kinase and cytokine receptors activate PI 3-kinase,
only insulin and insulin-like growth factor-1 (IGF-1)
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effectors following its activation by different receptors,
one possibility is that individual receptors may localize an
active PI 3-kinase to specific intracellular compartments,
thereby resulting in the modification of distinct pools of
PI by PI 3-kinase. The finding that PI(3,4,5)-P 3 is un-
likely to diffuse throughout the cell would suggest that it
functions primarily in the intracellular location where it
is made [19].
In addition, it is possible that the specificity of the
responses elicited by PI 3-kinase is also determined in
combination with PI 3-kinase-independent signaling
pathways that are activated by different receptors. We
think it likely that at least one other signaling pathway, in
addition to that involving PI 3-kinase, is necessary for
insulin to stimulate glucose uptake and GLUT4 translo-
cation: we found, for example, that activation of PI 3-
kinase by the IL-4 receptor is, in itself, not sufficient to
stimulate glucose uptake and GLUT4 translocation in L6
myoblasts [34]. We predict that active PI 3-kinase local-
izes to the same intracellular compartment in cells stimu-
lated with insulin and IL-4, so abnormal localization of
the active PI 3-kinase is unlikely to account for the fail-
ure of IL-4 to stimulate glucose uptake. In contrast to
other receptors, both the IL-4 and insulin receptors use
tyrosine-phosphorylated IRS-1 as an intermediate in
activating PI 3-kinase [35], and tyrosine-phosphorylated
IRS-1 has been shown to localize to the same intra-
cellular compartment as the active PI 3-kinase in insulin-
stimulated cells [36]. Thus, it now appears that under-
standing the mechanism whereby the insulin receptor
couples to glucose transport will require not only an
understanding of the role of PI 3-kinase in mediating
glucose uptake by insulin but also the identification of
the other signaling pathway(s) activated by insulin that
couple to this response.
Fig. 4. Expression of N17Rac1 inhibits insulin-stimulated
lamellipodial formation, but not glucose uptake, in 3T3-L1
adipocytes. (a) Cells were either not stimulated or stimulated with
100 nM insulin, and lamellipodia formation was determined as
described in Figure 2a. (b) Glucose uptake in 3T3-L1 adipocytes
expressing N17 Racl was assayed as described in Fig. 3.
have, thus far, been shown to stimulate GLUT4 trans-
location in insulin-sensitive cells. We have found that
activation of PI 3-kinase by receptors other then those
for insulin or IGF-1 does not stimulate GLUT4 translo-
cation [34]. Thus, the finding that Rac mediates some of
the responses involving PI 3-kinase, such as lamellipodial
formation, but does not mediate insulin-stimulated glu-
cose uptake, is consistent with the idea that some of the
specificity in the biological responses elicited by PI 3-
kinase may be mediated through its activation of different
effector molecules. Although it is still not clear how
PI 3-kinase is directed to couple to specific targeted
Although PI 3-kinase is probably one of the intracellular
signaling molecules responsible for coupling the insulin
receptor to GLUT4 translocation and glucose uptake in
insulin-sensitive cells, it is important to point out that
studies linking PI 3-kinase to glucose transport are based
mostly on the use of pharmacological inhibitors of PI 3-
kinase. Although these compounds appear to be specific
for PI 3-kinase when used at appropriate concentrations,
it may be premature to conclude that they do not inhibit
other molecules that are critical for glucose uptake. In
addition, a growing family of PI 3-kinases, distinct from
the heterodimeric p85-p110 PI 3-kinases that are acti-
vated by binding to IRS-1 in insulin-stimulated cells,
have been identified and have been found to be
inhibitable by wortmannin [37-40]. The roles of these
other PI 3-kinases in mediating cellular responses are still
not known. It is clear, therefore, that a full understanding
of the biological responses mediated by PI 3-kinases
will require not only the identification of downstream
targets for PI 3-kinase but also the use of more specific
inhibitors of the different PI 3-kinases, in order to deter-
mine which responses are mediated by the different
family members.
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Conclusions secondary anti-mouse antibody and visualized using enhanced
chemiluminescence.
The finding that Rac couples PI 3-kinase to some
biological responses has led to the suggestion that Rac is
the common mediator for a variety of responses medi-
ated by PI 3-kinase. In this report, we have shown that
Rac does not couple PI 3-kinase to glucose uptake in an
insulin-sensitive adipocyte cell line, so Rac does not
mediate all of the cellular responses stimulated by PI 3-
kinase. PI 3-kinase must mediate different cellular res-
ponses following its activation by different receptors; our
results suggest that some of the specificity in the biologi-
cal responses elicited by PI 3-kinase may arise through
the activation of a variety of different effector molecules.
Materials and methods
Cell lines, expression vectors and the production of
retroviruses
Murine 3T3-L1 cells were maintained in DMEM containing
10 % calf serum (Gibco, BRL). Two days after reaching con-
fluence, 3T3-L1 fibroblasts were differentiated into adipocytes
by incubation for 3 days in DMEM containing 10 % FBS,
1 J.M insulin, 0.5 mM 3-isobutyl-1-methylxanthine and 1 .M
dexamethasone [9]. Experiments on adipocytes were performed
10-20 days after differentiation. To overexpress V12 Racl and
N17 Racl in 3T3-L1 cells, the DNA sequence encoding the
Myc epitope fused to either the sequence encoding V12 Racl
or that encoding N17 Racl was subcloned into the retroviral
vector SRox [31,32,41]. Helper-free infectious retrovirus was
produced by transiently transfecting the Rac constructs into the
retroviral packaging cell line BOSC 23 using calcium phosphate
precipitation, as described [42]. Retroviruses expressing
V12 Racl or N17 Racl were used to infect 3T3-L1 fibroblasts
and geneticin-resistant pools and clonal cell lines were isolated.
Overexpression of the Rac constructs was determined by
immunoblotting using the anti-Myc antibody 9E10 [33].
Glucose uptake
Glucose uptake was assayed using 2-deoxy-D-[3 H]glucose, as
described previously [43]. 3T3-L1 cells were differentiated in
12-well plates as described above, and glucose uptake was
assayed on cells 10-20 days after differentiation. After overnight
starvation, cells were either not stimulated or stimulated with
100 nM insulin for 20 min at 37 C. Cells were then washed
twice with Hepes buffer (20 mM Hepes pH 7.4,
140 mM NaCI, 5 mM KCI, 2.5 mM MgSO4 and M CaC12),
and then incubated with transport solution (Hepes buffer con-
taining 0.5 l.Ci ml-' 2-deoxy-D-[3H]glucose and 10 p.M 2-
deoxy-D-glucose) for 10 min. Cells were washed three times
with ice-cold PBS and solubilized in 0.05 N NaOH. Uptake of
2-deoxy-D-[ 3H]glucose was determined by scintillation count-
ing. The total amount 2-deoxy-D-glucose in the cells was
determined from the uptake of 2-deoxy-D-[3 H]glucose and was
expressed in terms of total cell protein. Protein concentration
was determined using the Bradford method [44]. To determine
the effect of wortmannin on glucose uptake, adipocytes were
incubated with wortmannin 5 min prior to stimulation with
insulin and glucose uptake was determined as described above.
Cell lysis and immunoblotting
Cell lysis and immunoblotting were performed as described
previously [45]. The anti-Myc antibody was detected using a
Analysis of lamellipodia formation in 3T3-L 1 cells
expressing V12 RacI or N17 Racl
3T3-L1 fibroblasts infected with control virus, or cells
overexpressing V12 Rac or N17 Rac , were serum-starved for
16 h in DMEM containing 0.2 % FBS. Cells were then either
not stimulated or stimulated with 100 nM insulin, fixed for
10 min in 3.5 % formaldehyde and permeabilized with 0.2 %
Triton X-100. Actin filaments were detected using fluorescein
isothiocyanate-labeled phalloidin (FITC-phalloidin), as previ-
ously described [32,46]. To determine the effect of wortmannin
on membrane ruffling, appropriate samples were pretreated
with wortmannin for 5 min prior to stimulation with insulin.
Protein kinase assay
Lysates (100 .Lg) prepared from V12 Racl-infected 3T3-L1
fibroblasts and control cells were incubated with 10 .Lg
GST-cJun (containing amino acids 1-223 of cJun) coupled to
glutathione-agarose beads for 2 h at 4 C, as described [47].
After washing the beads three times with lysis buffer and once
with kinase buffer (20 mM Hepes pH 7.4, 20 mM MgC12,
10 mM NaF, 20 mM 3-glycerophosphate, 20 mM PNPP,
1 mM DTT and 0.2 mM orthovanadate), the kinase reaction
was started by incubating the beads in 50 p.l kinase buffer con-
taining 20 p.M cold ATP and y-[32P]ATP (15 ILCi per sam-
ple). After incubation at 30 C for 20 min, the reaction was
terminated by boiling the mixtures in sample buffer for 5 min
and the reaction products were separated by SDS-PAGE on
12 % gels.
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